⌘K

Home/Filings/4/0001127602-24-013916

4//SEC Filing

DeLuca Richard R. 4

Accession 0001127602-24-013916

CIK 0000310158other

View on SEC.gov Company Profile

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:05 PM ET

Size

9.4 KB

Accession

0001127602-24-013916

Insider Transaction Report

Form 4

Period: 2024-04-30

Merck & Co., Inc.MRK

DeLuca Richard R.

EVP&Pres, Merck Animal Health

Transactions

Award
Restricted Stock Unit
2024-04-30+23,216→ 23,216 total
From: 2027-04-30Exp: 2027-04-30→ Common Stock (23,216 underlying)
Award
Stock Option (Right to Buy)
2024-04-30+37,500→ 37,500 total
Exercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (37,500 underlying)

Holdings

Common Stock
136,593.559
Common Stock - 401(k) Plan
(indirect: By 401(k))
1,236.602

Footnotes (5)

[F1]Holdings include shares acquired in dividend reinvestment transactions.
[F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
[F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
[F4]These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 04/30/2027.
[F5]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1

filerCIK 0001421339

Filing Metadata

Form type: 4
Filed: May 1, 8:00 PM ET
Accepted: May 2, 4:05 PM ET
Size: 9.4 KB

View on SEC.gov